Zoetis Inc.ZTS
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · zoetis.com
Zoetis Inc. is a global animal health company engaged in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, and precision health solutions for livestock and companion animals worldwide. The company serves veterinarians, livestock producers, and pet owners with products spanning parasiticides, vaccines, anti-infectives, dermatology treatments, and diagnostics.
Key ratios
Operating cash flow growth
-4.6%TTM
2025
-1.7%2024
25.5%2023
23.1%
EPS growth
6.2%TTM
2025
10.1%2024
7.9%2023
12.9%
FCF / Sales
24.3%TTM
2025
24.1%2024
24.8%2023
19.0%
Net margin
27.7%TTM
2025
28.2%2024
26.9%2023
27.4%
ROA
15.4%TTM
2025
15.3%2024
14.9%2023
13.1%
ROE
66.0%TTM
2025
66.0%2024
51.1%2023
49.8%
Revenue growth
1.6%TTM
2025
2.3%2024
8.3%2023
5.7%
Recent news
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Zoetis Announces First Quarter 2026 Results
Zoetis Declares Second Quarter 2026 Dividend
Track ZTS in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer